Association between blood glucose levels and high-sensitivity cardiac troponin T in an overt cardiovascular disease-free community-based study

Diabetes Research and Clinical Practice

Volumn 97, Issue 1, 2012, Pages 139-145

  Zheng, Jin ^a   Ye, Ping ^a   Luo, Leiming ^a   Xiao, Wenkai ^a   Xu, Ruyi ^a   Wu, Hongmei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Community based study; High sensitivity cardiac troponin T; Hyperglycemia; Myocardial damage

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; TROPONIN T;

ADULT; ANTHROPOMETRY; ARTICLE; CARDIOVASCULAR RISK; CHINA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEART MUSCLE INJURY; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PROTEIN BLOOD LEVEL; RISK FACTOR;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SMOKING; TROPONIN T;

EID: 84864104888     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.04.021     Document Type: Article

References (21)

1. Wallace T.W., Abdullah S.M., Drazner M.H., Das S.R., Khera A., McGuire D.K., et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006, 113:1958-1965.
2. Daniels L.B., Laughlin G.A., Clopton P., Maisel A.S., Barrett-Connor E. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. J Am Coll Cardiol 2008, 52:450-459.
3. Reichlin T., Hochholzer W., Bassetti S., Steuer S., Stelzig C., Hartwiger S., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009, 361:858-867.
4. Omland T., de Lemos J.A., Sabatine M.S., Christophi C.A., Rice M.M., Jablonski K.A., et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009, 361:2538-2547.
5. Keller T., Zeller T., Peetz D., Tzikas S., Roth A., Czyz E., et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009, 361:868-877.
6. Latini R., Masson S., Anand I.S., Missov E., Carlson M., Vago T., et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007, 116:1242-1249.
7. Apple F.S., Jesse R.L., Newby L.K., Wu A.H., Christenson R.H. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Circulation 2007, 115:e352-e355.
8. de Lemos J.A., Drazner M.H., Omland T., Ayers C.R., Khera A., Rohatgi A., et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010, 304:2503-2512.
9. deFilippi C.R., de Lemos J.A., Christenson R.H., Gottdiener J.S., Kop W.J., Zhan M., et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010, 304:2494-2502.
10. Saunders J.T., Nambi V., de Lemos J.A., Chambless L.E., Virani S.S., Boerwinkle E., et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 2011, 123:1367-1376.
11. Everett B.M., Cook N.R., Magnone M.C., Bobadilla M., Kim E., Rifai N., et al. Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study. Circulation 2011, 123:2811-2818.
12. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension ESH-ESC Task Force on the management of arterial hypertension. J Hypertens 2007, 25:1751-1762.
13. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome: a Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
14. Zhang L., Zuo L., Xu G., Wang F., Wang M., Wang S., et al. Community-based screening for chronic kidney disease among populations older than 40 years in Beijing. Nephrol Dial Transplant 2007, 22:1093-1099.
15. Ma Y.C., Zuo L., Chen J.H., Luo Q., Yu X.Q., Li Y., et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006, 17:2937-2944.
16. Wu A.H.B. Biochemical markers of cardiac damage from traditional to cardiac specific proteins. Scand J Clin Lab Invest 1999, 59:74-80.
17. Atar D. New definition of myocardial infarction. BMJ 2008, 337:3078.
18. Morrow D.A., Antman E.M. Evaluation of high-sensitivity assays for cardiac troponin. Clin Chem 2009, 55:5-8.
19. Kahn B.B., Flier J.S. Obesity and insulin resistance. J Clin Invest 2000, 106:473-481.
20. Pickup J.C., Mattock M.B., Chusney G.D., Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997, 40:1286-1292.
21. Festa A., D'Agostino R., Howard G., Mykkänen L., Tracy R.P., Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome. Circulation 2000, 102:42-47.